XBRU:OXUR (Belgium)  
Oxurion NV logo

Oxurion NV

€ 0.11 (-11.51%) Oct 3
P/E:
At Loss
P/B:
0
Market Cap:
€ 6.15M ($ 6.08M)
Enterprise V:
€ 10.32M ($ 10.21M)
Volume:
393.48K
Avg Vol (2M):
233.47K
Also Trade In:
Volume:
393.48K
Market Cap €:
6.15M
Market Cap $:
6.08M
PE Ratio:
At Loss
Avg Vol (2-Month):
233.47K
Enterprise Value €:
10.32M
Enterprise Value $:
10.21M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Oxurion NV is a biopharmaceutical company. The company is focused on developing treatments to preserve vision for patients with diseases affecting the back of the eye. It has developed a diverse portfolio of disease-modifying drug candidates, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide. It owns the global rights to Jetrea (ocriplasmin), the pharmacological vitreolysis drug approved for the treatment of symptomatic vitreomacular adhesion (in the U.S.) and vitreomacular traction (outside the U.S.).
Name Current Vs Industry Vs History
Cash-To-Debt 0.49
Equity-to-Asset -0.12
Debt-to-Equity -5.31
Debt-to-EBITDA -0.32
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.84
Distress
Grey
Safe
Beneish M-Score -4.84
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 21.89
9-Day RSI 23.01
14-Day RSI 25.25
6-1 Month Momentum % -86.2
12-1 Month Momentum % -89.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.96
Quick Ratio 0.95
Cash Ratio 0.47
Days Inventory 46.04
Days Sales Outstanding 648.81
Days Payable 2949.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.7

Financials

XBRU:OXUR's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 1.055
EPS (TTM) (€) -0.659
Beta 0.57
Volatility % 78.53
14-Day RSI 25.25
14-Day ATR (€) 0.018236
20-Day SMA (€) 0.167925
12-1 Month Momentum % -89.9
52-Week Range (€) 0.11 - 2.59
Shares Outstanding (Mil) 55.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Oxurion NV Filings

Document Form Filing Date
No Filing Data

Oxurion NV Analysis

Share your research